Chronic graft-versus-host disease is a serious complication that can develop after a person receives donated stem cells from another person during a bone marrow or stem cell transplant. This condition occurs when the donor’s immune cells, which were meant to help the patient, begin to attack the patient’s own organs and tissues. While most cases are mild to moderate, chronic graft-versus-host disease can affect many parts of the body and often requires years of treatment and specialized care.

Understanding Chronic Graft-Versus-Host Disease

Chronic graft-versus-host disease, often called chronic GVHD or cGVHD, is different from its acute counterpart. It typically develops more slowly and can appear at any time after a transplant, though most cases begin within the first two years following the procedure. Unlike acute GVHD, which usually affects the skin, digestive system, and liver within the first 100 days after transplant, chronic GVHD can involve many more organs and tissues throughout the body.^[1]

When someone undergoes an allogeneic transplant (a transplant using donor cells from another person), the donated hematopoietic stem cells (immature blood cells) eventually mature and become part of the patient’s new immune system. In chronic GVHD, these donor cells mistakenly identify the patient’s own tissues as foreign threats and launch an attack against them. This is why the condition is called “graft versus host”—the graft (donated cells) attacks the host (the patient).^[1]

The development of chronic GVHD involves a complex process that begins with early inflammation and tissue injury, followed by ongoing inflammation, abnormal tissue repair, and eventually fibrosis (tissue thickening and scarring). This process is similar to what happens in certain autoimmune diseases, where the body’s immune system mistakenly attacks healthy tissues.^[8]

Who Is at Risk for Chronic GVHD?

Not everyone who receives a stem cell transplant will develop chronic GVHD, but certain factors can increase the likelihood. Understanding these risk factors helps patients and their healthcare teams remain vigilant for early signs of the condition.^[3]

People who previously experienced acute graft-versus-host disease are at higher risk of developing the chronic form. This connection suggests that the initial immune response may set the stage for long-term complications. Age also plays a role, with older transplant recipients facing a greater chance of developing chronic GVHD compared to younger patients.^[3]

The source and type of donor cells matter as well. Patients who receive stem cells from an unrelated donor or a donor who is not a perfect match face increased risk. The method of stem cell collection also influences risk—cells collected from the bloodstream (peripheral blood stem cells) rather than bone marrow or cord blood carry a higher likelihood of causing chronic GVHD.^[3]

Gender combinations between donor and recipient create additional risk factors. Male patients who receive cells from female donors face elevated risk, as do any patients (male or female) who receive cells from female donors who have previously been pregnant. These patterns relate to how the immune system recognizes and responds to certain proteins present in the body.^[3]

How Common Is Chronic GVHD?

Chronic graft-versus-host disease ranks as one of the most common complications following allogeneic stem cell transplantation. Depending on various patient and transplant factors, chronic GVHD affects approximately 30 to 70 percent of people who survive beyond 100 days after their transplant. The condition typically appears with a median onset of four to six months following the transplant procedure.^[7]

The number of people living with chronic GVHD has grown in recent years. As transplant procedures have become safer and more people undergo these lifesaving treatments, the population of individuals who ultimately develop chronic GVHD has expanded. This increase has prompted more intensive research into prevention and treatment strategies for the condition.^[5]

Most cases of chronic GVHD fall into the mild or moderate category, which offers some reassurance to patients and their families. However, approximately 10 to 15 percent of patients develop more severe symptoms that significantly impact their daily lives and require extensive medical management.^[3]

Signs and Symptoms That Affect Daily Life

Chronic GVHD can affect virtually any part of the body, and symptoms vary widely from person to person. The condition most commonly targets the skin, eyes, mouth, liver, lungs, and gastrointestinal tract, though it can also affect muscles, joints, and genitals. Understanding these symptoms helps patients recognize problems early and seek appropriate care.^[1]

Skin changes are among the most visible signs of chronic GVHD. Many patients develop rashes that may feel itchy or uncomfortable. The skin can become tight and swollen, and some people experience hair loss on their head and body. These changes can affect a person’s appearance and self-esteem, making them particularly difficult to cope with emotionally.^[1]

Eye symptoms can significantly impact quality of life. Many patients experience dry or gritty-feeling eyes, as if sand or dust is constantly irritating them. Vision changes may occur, and the eyes might feel persistently uncomfortable. These symptoms require careful monitoring, as some eye problems from chronic GVHD can become permanent if not addressed promptly.^[4]

The mouth and digestive system frequently show signs of chronic GVHD. Dry mouth is common, along with mouth sores and gum disease. Some patients develop painless white lines on their tongue or inner cheeks. The mouth may become so sensitive that spicy or acidic foods cause discomfort. Opening the mouth widely can become difficult for some individuals. Digestive symptoms include nausea, vomiting, and diarrhea, which can lead to weight loss and nutritional concerns.^[4]

When chronic GVHD affects the lungs, patients may develop a persistent dry cough that doesn’t go away. Shortness of breath during normal activities can make everyday tasks challenging. These respiratory symptoms require careful evaluation, as lung involvement can significantly impact a person’s ability to function normally.^[1]

Muscle and joint involvement causes weakness, cramping, or pain. Some patients notice a decreased range of motion in their joints, making movement more difficult. These symptoms can affect mobility and independence, requiring physical therapy and other supportive interventions.^[1]

Genital symptoms affect both men and women with chronic GVHD. Women may experience vaginal dryness, itchiness, or pain during intercourse. Men might notice itching of the penis or scrotum, or discomfort during sexual activity. These symptoms can be embarrassing to discuss but are important to address with healthcare providers.^[1]

Many patients with chronic GVHD experience overwhelming fatigue that doesn’t improve with rest. This exhaustion can make it difficult to work, care for family, or engage in activities that once brought joy. The liver may also be affected, sometimes causing jaundice (a yellowing of the skin and eyes), though this is less common than other symptoms.^[1]

What Causes the Immune System to Attack?

Understanding why chronic GVHD develops requires looking at how the immune system normally protects the body. Blood cells in a healthy immune system defend against infections by recognizing and fighting invaders like viruses and bacteria. These protective cells know not to attack the body’s own tissues because they recognize a protein marker called human leukocyte antigen (HLA) on the surface of the body’s cells.^[1]

During an allogeneic stem cell transplant, donor cells enter the patient’s body with a mission to rebuild the immune system. However, these donor cells carry their own set of recognition markers that may differ from the patient’s original markers. When the differences are significant enough, the donor’s immune cells perceive the patient’s tissues as foreign and dangerous, triggering an immune attack.^[2]

The pathophysiology of chronic GVHD involves multiple steps. It begins with damage to tissues, often during the conditioning treatment (chemotherapy or radiation) given before the transplant. This initial injury releases signals that activate the donor’s immune cells. T lymphocytes (a type of white blood cell) from the donor graft become particularly active, recognizing differences between donor and recipient tissues.^[2]

Once activated, these donor T cells multiply and release chemical messengers called cytokines, which promote inflammation throughout the body. This inflammatory response doesn’t resolve as it normally would. Instead, it persists and evolves into chronic inflammation. Over time, the ongoing immune activity leads to abnormal tissue repair processes, causing fibrosis—the thickening and scarring of tissues that characterizes many chronic GVHD symptoms.^[8]

Preventing Chronic GVHD

Prevention of chronic GVHD begins before the transplant even takes place. Healthcare providers use several strategies to reduce the risk that donor cells will attack the patient’s tissues. These preventive measures have improved significantly over the years, though they cannot eliminate the risk entirely.^[9]

Careful donor matching represents the first line of defense. Transplant teams work to find donors whose HLA markers match the patient’s as closely as possible. The better the match, the lower the risk of GVHD. However, even perfectly matched donors can sometimes trigger GVHD, and patients who need transplants urgently may not have time to wait for a perfect match.^[2]

Immunosuppressive medications given around the time of transplant help prevent the donor’s immune cells from becoming overactive. Common preventive drugs include combinations of medications that calm the immune system and reduce its ability to attack the patient’s tissues. These medications must be carefully balanced—suppressing the immune system too much can leave patients vulnerable to dangerous infections, while suppressing it too little allows GVHD to develop.^[7]

Some transplant centers use techniques to remove certain T cells from the donor’s stem cells before the transplant. This T-cell depletion can reduce GVHD risk, though it also affects how well the new immune system fights cancer cells and infections. Healthcare teams must weigh these competing concerns when developing each patient’s transplant plan.^[2]

The choice between different sources of stem cells also factors into prevention strategies. Bone marrow, peripheral blood, and umbilical cord blood each carry different levels of GVHD risk. While peripheral blood stem cells are easier to collect and lead to faster immune system recovery, they’re also associated with higher rates of chronic GVHD compared to bone marrow or cord blood.^[3]

How the Body Changes in Chronic GVHD

The physical and biochemical changes that occur in chronic GVHD reflect the complex interaction between the donor’s immune system and the patient’s tissues. These changes explain why symptoms develop and why certain organs are particularly vulnerable to damage.^[8]

In the skin, chronic inflammation leads to changes in the deepest layers where collagen (a structural protein) is produced. The body produces too much collagen in response to the ongoing immune attack, causing skin to become thick, tight, and less flexible. This process resembles what happens in scleroderma, an autoimmune disease characterized by skin hardening. Some patients lose the ability to sweat normally as sweat glands become damaged, and hair follicles may stop producing hair.^[8]

Eye dryness in chronic GVHD results from inflammation and damage to the tear-producing glands. Without adequate tears, the surface of the eye (cornea) can become scratched and damaged. Similar problems affect the salivary glands in the mouth, reducing saliva production and causing persistent dry mouth. This dryness creates an environment where mouth sores develop more easily and dental problems become more common.^[4]

In the liver, donor immune cells infiltrate liver tissue and attack the cells lining the small bile ducts. These ducts normally carry bile (a digestive fluid) away from the liver. When the ducts become inflamed and damaged, bile backs up in the liver, causing liver enzymes to rise in blood tests. In severe cases, this can lead to jaundice and impaired liver function.^[7]

Lung involvement in chronic GVHD often affects the small airways called bronchioles. Inflammation and scarring narrow these airways, making breathing difficult. This condition, called bronchiolitis obliterans, can be progressive and requires careful monitoring. Pulmonary function tests help doctors track how well the lungs are working over time.^[7]

When chronic GVHD affects the digestive tract, inflammation damages the lining of the intestines and esophagus. This disrupts normal digestion and absorption of nutrients. Patients may experience difficulty swallowing, persistent nausea, or chronic diarrhea. These digestive problems can lead to weight loss and malnutrition if not properly managed.^[1]

In muscles and joints, chronic inflammation triggers fibrosis in the tissues that surround and support these structures. The fascia (connective tissue) becomes thickened and contracted, restricting movement. Muscles themselves may weaken due to inflammation and reduced use. These changes can significantly limit mobility and make everyday activities challenging.^[1]

The Long Road of Treatment and Recovery

Treatment for chronic GVHD represents a lengthy commitment, with most patients requiring therapy for three to five years. Approximately 15 percent of patients need treatment for even longer periods, and in rare cases, some individuals require lifelong immunosuppressive medication to keep their symptoms under control.^[3]

Systemic corticosteroids, such as prednisone, remain the first-line treatment when chronic GVHD affects multiple organs or causes significant symptoms. These powerful anti-inflammatory drugs help calm the overactive immune response. However, long-term steroid use carries its own risks, including bone thinning, increased infection risk, mood changes, weight gain, and elevated blood sugar. Healthcare providers work to use the lowest effective dose and taper steroids as soon as symptoms allow.^[7]

For patients whose chronic GVHD affects only one or two organs with mild symptoms, localized therapies may suffice. Skin ointments, eye drops, or other targeted treatments can address specific problem areas without exposing the entire body to immunosuppressive medications. This approach minimizes side effects while still providing symptom relief.^[3]

When initial steroid treatment doesn’t adequately control symptoms—a situation called steroid-refractory chronic GVHD—doctors turn to additional medications. Several newer drugs have been approved specifically for treating chronic GVHD that hasn’t responded to steroids. These include ibrutinib, ruxolitinib, and belumosudil, which work through different mechanisms to reduce inflammation and fibrosis. The choice among these agents depends on the patient’s specific symptoms, which organs are affected, and other individual factors.^[9]

Other medications used for difficult-to-treat chronic GVHD include drugs originally developed for other purposes but found to be helpful in GVHD. These include mycophenolate mofetil, sirolimus, methotrexate, and various targeted therapies. Some patients benefit from extracorporeal photopheresis, a procedure where blood is removed, treated with light-activated medication, and returned to the body.^[3]

Managing chronic GVHD requires more than just medication. Many patients need specialized care from multiple healthcare providers, including dermatologists for skin problems, ophthalmologists for eye issues, pulmonologists for lung complications, and gastroenterologists for digestive symptoms. Physical therapists help maintain mobility when muscles and joints are affected. This multidisciplinary approach ensures that each aspect of the disease receives appropriate attention.^[8]

Supportive care plays a vital role in managing symptoms and maintaining quality of life. Patients with dry eyes need frequent lubricating eye drops and may benefit from special moisture-preserving eyewear. Those with dry mouth require careful dental hygiene, frequent sips of water, and sometimes medications that stimulate saliva production. Skin care with gentle moisturizers helps manage dryness and itching. Nutritional support becomes important when eating is difficult or when digestive problems interfere with nutrient absorption.^[3]

Living With the Emotional Impact

The emotional and psychological burden of chronic GVHD can be as challenging as the physical symptoms. Many patients describe living with the condition as a full-time job, requiring constant vigilance, medical appointments, and self-care activities. This reality can be overwhelming, especially for people who have already endured the stress of cancer diagnosis, intensive treatment, and transplant recovery.^[13]

Before chronic GVHD even develops, transplant recipients have typically experienced an emotional marathon. The journey includes the shock of cancer diagnosis, the search for a suitable donor, intensive pre-transplant chemotherapy with difficult side effects, weeks or months hospitalized away from home, and a slow recovery period requiring isolation from loved ones to avoid infections. Adding chronic GVHD on top of this journey can feel unbearable.^[11]

Depression and anxiety commonly affect people living with chronic GVHD. The unpredictable nature of the disease—not knowing whether symptoms will improve or worsen—creates significant stress. Physical changes like skin rashes, hair loss, and weight fluctuations can affect self-esteem and body image. Pain, fatigue, and mobility limitations may prevent people from working, socializing, or engaging in activities they once enjoyed, leading to feelings of loss and isolation.^[14]

Some medications used to treat chronic GVHD, particularly steroids, can themselves affect mood and mental health. Patients may experience mood swings, irritability, anxiety, or confusion as side effects of their treatment. Recognizing these symptoms as potentially medication-related rather than personal failings is important. Healthcare providers can sometimes adjust medications or add supportive treatments to help manage these effects.^[10]

The relationship strain caused by chronic GVHD shouldn’t be underestimated. Patients often feel guilty about relying heavily on caregivers, typically spouses or family members. Sexual problems caused by GVHD symptoms can affect intimate relationships. Children of patients may struggle to understand why their parent is still sick after the transplant was supposed to make them better. These family dynamics require attention and often benefit from professional counseling.^[11]

Coping strategies that help many patients include taking each day as it comes rather than worrying excessively about the future. Focusing on what you can do rather than what you can’t helps maintain a sense of control. Building flexibility into plans acknowledges that symptom severity varies day to day. Finding moments of joy in small things—a favorite food, time with pets, listening to music—reminds patients of their identity beyond being sick.^[10]

Talking about feelings, rather than suppressing them, provides important emotional release. Speaking with a psychologist, social worker, or counselor experienced in working with transplant patients can be tremendously helpful. Many transplant centers offer mental health services as part of comprehensive care. Support groups where patients can connect with others who truly understand their experience provide validation and practical coping strategies.^[10]

Meditation, guided imagery, and relaxation techniques help many patients manage stress and anxiety. These practices don’t cure chronic GVHD, but they can make the emotional burden more bearable. Mindfulness—the practice of staying present in the current moment rather than dwelling on past losses or future worries—offers another valuable coping tool.^[10]

The Importance of Comprehensive Care

Successful management of chronic GVHD depends on close collaboration between patients, caregivers, and a team of healthcare professionals. Because the disease can affect so many different body systems, no single doctor can address all the complications that may arise. This makes coordinated, multidisciplinary care essential for optimal outcomes.^[8]

The transplant team typically coordinates overall care, but patients often need to see various specialists for organ-specific problems. Regular monitoring through physical examinations, blood tests, and sometimes imaging studies helps detect new problems early and track how well treatments are working. Pulmonary function tests may be performed periodically to monitor lung health. Eye examinations check for changes in vision and tear production. Skin examinations assess the extent and severity of rashes or thickening.^[14]

Preventing infections becomes critically important for people taking immunosuppressive medications for chronic GVHD. These drugs that calm the overactive immune response also reduce the body’s ability to fight off bacteria, viruses, and fungi. Patients typically receive preventive antibiotics and antiviral medications. Staying up to date with recommended vaccinations, avoiding crowds during flu season, and practicing good hand hygiene all help reduce infection risk.^[3]

Quality of life considerations should guide treatment decisions throughout the chronic GVHD journey. Sometimes less aggressive treatment that allows better function and fewer side effects is preferable to more intensive therapy that controls symptoms but leaves patients feeling miserable. Healthcare providers increasingly recognize that the goal isn’t just to treat the disease but to help patients live as fully as possible despite their condition.^[8]

Research into better treatments for chronic GVHD continues actively. Clinical trials test new medications and treatment approaches that may offer improved outcomes with fewer side effects. Patients with chronic GVHD who haven’t responded well to standard treatments might consider participating in clinical trials, which provide access to promising new therapies while contributing to medical knowledge that helps future patients.^[5]

Hope exists for people diagnosed with chronic GVHD. While the disease presents significant challenges, many patients see gradual improvement over time. Active chronic GVHD most often resolves within five to eight years for most people, though the journey requires patience and persistence. Advances in treatment over the past decade have provided more options than ever before, and ongoing research continues to improve the outlook for people living with this complex condition.^[5]